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10 Adult and atypical cystic ﬁbrosis In Serbia
D. Radojkovic1, A. Nikoliæ1, M. Mitic-Milikic2, M. Grujic2. 1IMGGE, Belgrade,
Yugoslavia; 2Institute for Pulmonary Diseases and TB, Clinical Center of Serbia,
Belgrade, Yugoslavia.
Cystic ﬁbrosis (CF) has been described as a severe disease mainly conﬁne to
children. During last decades, survival has improved dramatically, and the vast
majority of patients with CF now live into adult age. On the other hand, in the
recent years, an increased number of patients have been diagnosed in adulthood
with atypical disease. Patients with CF may thus present at adult age in a diversity
of clinical disciplines with single or multiple organ disease. Currently, there are
more than 200 CF patients in Serbia, of which 40% are adults. Recently, the
Center for adult CF has been established in the Institute of Pulmonary Disease
and TB. We present the results of extensive genetic analysis of the CFTR gene was
performed in 51 adult patients with the following working diagnosis: disseminated
bronchiectasias, chronic bronchitis and pulmonary emphysema. Of the 51 patients
studied, 4 had two mutations in the CFTR gene, 8 had one mutation, and in
5 patients, 5T variant has been present. Our study illustrates the usefulness of
molecular testing in assisting clinicians in a diagnosis of patients presenting with
atypical CF simptomatology.
Supported by: EuroGentest, Ministry of Science and Environmental Protection of
Republic of Serbia.
11 Do people with Cystic Fibrosis (CF) and one R117H allele have
less severe phenotype compared with DF508 homozygotes?
D. Shimmin, J. Rendall, J. Bradley, J.S. Elborn. Regional Adult CF Centre, Belfast
City Hospital, Belfast, United Kingdom
In Northern Ireland, 2 of the major CF mutations are DF508 (54%) and
R117H (5%). DF508 is a Class I, ‘severe’ mutation associated with classic CF
phenotype. R117H is a class IV, ’mild’ mutation associated with variable phenotype
and pancreatic sufﬁciency.
Aim: To compare the phenotype of people with CF and one R117H allele with an
age and gender matched group of DF508 homozygotes.
Methods: A retrospective study was carried out comparing pulmonary function
(FEV1%) bacteriology status and pancreatic status in 24 CF patients with one
R117H allele (16/24 DF508:R117H, 8/24 R117H:another) with a matched group of
24 DF508 homozygotes. The groups were matched to age: R117H group, 24(7) yrs;
DF508 group, 25(6) yrs, and gender; both R117H and DF508 groups, 15 male,
9 female. Data was extracted from patient records from a period when patients
were clinically stable (<10% change in spirometry from baseline in last 6 months).
Analysis: Independent t-tests; p value <0.05 was considered signiﬁcant.
Results: The R117H group had signiﬁcantly higher FEV1% than the DF508 group:
87 (13)% vs 60 (20)%(p< 0.001). Signiﬁcantly more people in the DF508 group
(21/24) were chronically infected with either Pseudomonas aeruginosa (PA) (n = 17)
or Burkholderia cepacia complex (BCC) (n = 4) compared to 5/24 people in the
R117H group (n = 5 PA; n = 0 BCC). Of the 5/24 in the R117H group chronically
infected with PA or BCC, 4/5 were DF508:R117H genotype. Signiﬁcantly more
R117H patients than DF508 patients were pancreatic sufﬁcient: 14/24 vs 1/24. The
R117H group had signiﬁcantly higher BMI than the DF508 group: 25(4) kg/m2 vs
22(3) kg/m2 (p = 0.01).
Conclusion: This study shows that patients with R117H allele have a milder
pulmonary and pancreatic phenotype than DF508 homozygotes.
12* Modulatory effect of MBL2 on the onset of Pseudomonas
aeruginosa infection is inﬂuenced by the TGFb1 variants in
pediatric CF patients
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Mannose-binding lectin 2 (MBL2) has been studied as a CF modiﬁer however there
is no consensus on its CF phenotype modulating effect. Reported outcomes ranged
from MBL2 acting as a modiﬁer of pulmonary function, infection status, liver
disease and survival to no effect at all. Here we present results of an MBL2 study
in a large cohort of CF patients (N = 1375). MBL2 gene diplotypes reconstructed
from genotypes of the promoter variant at position −221 (X/Y) and exon 1 mutations
(codons 52, 54, and 57) were clustered into three diplotype groups based on MBL2
plasma measurements in 2002 individuals. The groups represented low, intermediate
and high MBL2 expression in plasma. The MBL2 levels were signiﬁcantly increased
in CF patients as compared to parental MBL2 levels, most likely reﬂecting the gene’s
induction related to a bacterial infection. Analysis of age at ﬁrst P. aeruginosa
infection (agePA1) in the three MBL2 diplotype groups demonstrated a strong
modulation effect for agePA1 associated with the MBL2 levels. Most notably, the
diplotype group corresponding to MBL2 deﬁciency was signiﬁcantly associated
with early acquisition of PA in the pediatric cohort (p = 0.002). Analysis of the
TGFb1 codon 10 in combination with MBL2 groups showed that the MBL2 effect
on agePA1 was signiﬁcant for TGFb1 genotypes containing a high producer C allele
(C/C p = 0.02 and C/T p = 0.03), but not for TGFb1 genotype T/T. We conclude that
a low TGFb1 production associated with the TT genotype counteracts the effect of
MBL2 on agePA1 in pediatric CF patients.
Supported by: Genome Canada through OGI and CCFF.
13 Genetic markers of musculoskeletal changes in cystic ﬁbrosis
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Advances in treatment of CF patients have increased life expectancy from approx-
imately two to over 30 years. Because of this, there is an increased interest in
musculoskeletal system pathology in these patients. The group of 72 unrelated Pol-
ish CF children (all Caucasian), 40 girls and 32 boys, aged 5−20 years with known
genotypes were enrolled in the study. Clinical data were recorded and analysed.
Bone mineral density (BMD) at L1-L4 lumbar spine was measured. Polymorphisms
in COLIA1 (BalI, RsaI), VDR (ApaI, BsmI, FokI, TaqI) and CALCR (AluI) genes
were identiﬁed. Reduced BMD is common in Polish CF children. In 52% of cases
(37 CF patients) decreased BMD in comparison to healthy peers was identiﬁed.
Fourteen patients (20%) had Z-score <−1 SD and for 23 subjects (32%) Z-score
<−2 was observed. Median Z-score at L1-L4 lumbar spine was lower in patients
who had F508del allele (−1,2 SD) in comparison to those with no F508del allele
(−1 SD). More severe lung disease, pancreatic insufﬁciency, corticoid therapy and
male sex were independently associated with reduced bone mineral density. Possible
correlations between s (BalI, COLIA1), B (BsmI, VDR), f (FokI, VDR), t (TaqI,
VDR) C (AluI, CALCR) and F508del (CFTR) alleles and decreased BMD were
found. The mechanism of action of these alleles remains to be elucidated. COLIA1,
VDR and CALCR polymorphisms and F508del mutation in CFTR gene were shown
to be one of the factors determining BMD in 72 Polish children with cystic ﬁbrosis.
